Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

JDOC vs QAAGZX overlap: 58% of top holdings shared

Bottom line

How much do JDOC and QAAGZX overlap?

58% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 52.2% of JDOC's assets and 49.3% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.

QAAGZX holds far more positions (277 vs 61), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

JDOCQAAGZX
Weight overlap (top 25)58%
Shared holdings13
Weight in shared holdings52.2%49.3%
Total positions61277
Expense ratio0.65%0.86%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings JDOC and QAAGZX have in common

Holding% of JDOC% of QAAGZXOverlap
AbbVie, Inc.7.85%5.12%5.12%
Eli Lilly & Co.7.76%14.06%7.76%
UnitedHealth Group, Inc.5.85%5.88%5.85%
Merck & Co., Inc.4.82%4.00%4.00%
Johnson & Johnson4.82%6.64%4.82%
Thermo Fisher Scientific, Inc.3.73%2.53%2.53%
Bristol-Myers Squibb Co.3.57%2.12%2.12%
Abbott Laboratories3.11%1.91%1.91%
CVS Health Corp.2.83%0.93%0.93%
Stryker Corp.2.23%1.78%1.78%
Danaher Corp.2.16%1.44%1.44%
Intuitive Surgical, Inc.1.93%1.89%1.89%
Cardinal Health, Inc.1.51%1.04%1.04%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in JDOC

  1. AstraZeneca plc — 3.76%
  2. Roche Holding AG — 2.82%
  3. Novo Nordisk A/S — 2.61%
  4. GSK plc — 2.47%
  5. Cencora, Inc. — 2.07%
  6. Argenx SE — 2.06%
  7. Edwards Lifesciences Corp. — 1.73%
  8. IQVIA Holdings, Inc. — 1.71%
  9. Teva Pharmaceutical Industries Ltd. — 1.60%
  10. Regeneron Pharmaceuticals, Inc. — 1.60%
  11. Novartis AG — 1.60%
  12. Biogen, Inc. — 1.56%

Only in QAAGZX

  1. Gilead Sciences Inc — 2.79%
  2. Vertex Pharmaceuticals Inc — 2.26%
  3. Amgen Inc — 1.80%
  4. Elevance Health Inc — 1.54%
  5. Natera Inc — 1.44%
  6. Guardant Health Inc — 1.22%
  7. Royalty Pharma Plc- Cl A — 0.97%
  8. Tenet Healthcare Corp — 0.94%
  9. Kymera Therapeutics Inc — 0.89%
  10. T. Rowe Price Government Reserve Fund — 0.87%
  11. Protagonist Therapeutics Inc — 0.85%
  12. Moderna Therapeutics Inc — 0.83%

Asset mix

Asset typeJDOCQAAGZX
Stocks99.2%96.9%
Preferred stock—2.2%
Cash & short-term funds—0.9%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryJDOCQAAGZX
US75.2%92.3%
GB6.2%1.8%
CH4.4%0.5%
DK4.0%0.7%
JP2.5%0.5%
NL2.4%1.0%
DE1.9%—
IL1.6%0.2%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do JDOC and QAAGZX overlap?
About 58% by weight. 13 securities appear in both funds' top 25 holdings; they make up 52.2% of JDOC's assets and 49.3% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do JDOC and QAAGZX have in common?
The largest shared holdings are Eli Lilly & Co., UnitedHealth Group, Inc., AbbVie, Inc., Johnson & Johnson, Merck & Co., Inc..
Should I own both JDOC and QAAGZX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, JDOC or QAAGZX?
QAAGZX is broader, with 277 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.